BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29644579)

  • 21. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
    Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML
    Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quality of reporting general safety parameters and immune-related adverse events in clinical trials of FDA-approved immune checkpoint inhibitors.
    Karimian Z; Mavoungou S; Salem JE; Tubach F; Dechartres A
    BMC Cancer; 2020 Nov; 20(1):1128. PubMed ID: 33225901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials on drug-drug interactions registered in ClinicalTrials.gov reported incongruent safety data in published articles: an observational study.
    Jurić D; Pranić S; Tokalić R; Milat AM; Mudnić I; Pavličević I; Marušić A
    J Clin Epidemiol; 2018 Dec; 104():35-45. PubMed ID: 30081071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
    Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
    Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Publication of clinical trials supporting successful new drug applications: a literature analysis.
    Lee K; Bacchetti P; Sim I
    PLoS Med; 2008 Sep; 5(9):e191. PubMed ID: 18816163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second thoughts on the final rule: An analysis of baseline participant characteristics reports on ClinicalTrials.gov.
    Cahan A; Anand V
    PLoS One; 2017; 12(11):e0185886. PubMed ID: 29107973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Big Data Mining and Adverse Event Pattern Analysis in Clinical Drug Trials.
    Federer C; Yoo M; Tan AC
    Assay Drug Dev Technol; 2016 Dec; 14(10):557-566. PubMed ID: 27631620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unreported links between trial registrations and published articles were identified using document similarity measures in a cross-sectional analysis of ClinicalTrials.gov.
    Dunn AG; Coiera E; Bourgeois FT
    J Clin Epidemiol; 2018 Mar; 95():94-101. PubMed ID: 29277557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tocilizumab in rheumatoid arthritis: a case study of safety evaluations of a large postmarketing data set from multiple data sources.
    Curtis JR; Perez-Gutthann S; Suissa S; Napalkov P; Singh N; Thompson L; Porter-Brown B;
    Semin Arthritis Rheum; 2015 Feb; 44(4):381-8. PubMed ID: 25300699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
    Prayle AP; Hurley MN; Smyth AR
    BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
    Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
    BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serious adverse drug events related to non-investigational drugs in academic clinical trials: another source of safety data for risk assessment?
    Olivier P; Gimbert A; Colin AL; Salvo F; Becker M; Marty V; Montastruc JL; Petitpain N
    Br J Clin Pharmacol; 2016 Oct; 82(4):1069-75. PubMed ID: 27276241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
    Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
    JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA.
    Talebi R; Redberg RF; Ross JS
    Trials; 2020 Jul; 21(1):675. PubMed ID: 32703252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Power and meaninglessness.
    Bogduk N
    Pain Med; 2012 Feb; 13(2):148-9. PubMed ID: 22313497
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trial registry use in anaesthesiology systematic reviews: A cross-sectional study of systematic reviews published in anaesthesiology journals and the Cochrane Library.
    Umberham BA; Detweiler BN; Sims MT; Vassar M
    Eur J Anaesthesiol; 2017 Dec; 34(12):797-807. PubMed ID: 28731924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting of studies on new medicines in major medical journals: a case study in breast cancer.
    Vitry AI
    Clin Pharmacol Ther; 2010 Apr; 87(4):398-400. PubMed ID: 20305673
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.